KU 415 (Lansoprazole Delayed-Release 15 mg)
Pill with imprint KU 415 is Purple / White, Capsule-shape and has been identified as Lansoprazole Delayed-Release 15 mg. It is supplied by Lannett Company, Inc..
Lansoprazole is used in the treatment of gerd; barrett's esophagus; duodenal ulcer; aspiration pneumonia; duodenal ulcer prophylaxis (and more), and belongs to the drug class proton pump inhibitors. There is no proven risk in humans during pregnancy. Lansoprazole 15 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for KU 415
Lansoprazole Delayed-Release
- Imprint:
- KU 415
- Strength:
- 15 mg
- Color:
- Purple / White
- Shape:
- Capsule-shape
- Availability:
- Rx and/or OTC
- Drug Class:
- Proton pump inhibitors
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- Not a controlled drug
- Labeler / Supplier:
- Lannett Company, Inc.
- National Drug Code (NDC):
- 62175-0415
More about lansoprazole
- Lansoprazole Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Patient Tips
- Drug Images
- Drug Interactions
- Compare Alternatives
- Support Group
- Pricing & Coupons
- 75 Reviews
- Drug class: proton pump inhibitors
Consumer resources
- Lansoprazole
- Lansoprazole Orally Disintegrating Tablets
- Lansoprazole Delayed-Release Capsules
- Lansoprazole (Advanced Reading)
Other brands: Prevacid, Prevacid SoluTab, Prevacid OTC
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
